Ezetimibe Versus Nutraceuticals in Statin-intolerant Patients
NCT01490229
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
Ezetimibe
DRUG:
Nutraceuticals
Sponsor
University of Roma La Sapienza